GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Solarvest BioEnergy Inc (TSXV:SVS.H) » Definitions » EV-to-EBITDA

Solarvest BioEnergy (TSXV:SVS.H) EV-to-EBITDA : -2.81 (As of May. 24, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Solarvest BioEnergy EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Solarvest BioEnergy's enterprise value is C$4.28 Mil. Solarvest BioEnergy's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was C$-1.52 Mil. Therefore, Solarvest BioEnergy's EV-to-EBITDA for today is -2.81.

The historical rank and industry rank for Solarvest BioEnergy's EV-to-EBITDA or its related term are showing as below:

TSXV:SVS.H' s EV-to-EBITDA Range Over the Past 10 Years
Min: -4.63   Med: -2.55   Max: -1.98
Current: -2.81

During the past 13 years, the highest EV-to-EBITDA of Solarvest BioEnergy was -1.98. The lowest was -4.63. And the median was -2.55.

TSXV:SVS.H's EV-to-EBITDA is not ranked
in the Biotechnology industry.
Industry Median: 10.33 vs TSXV:SVS.H: -2.81

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-24), Solarvest BioEnergy's stock price is C$0.025. Solarvest BioEnergy's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was C$-0.025. Therefore, Solarvest BioEnergy's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Solarvest BioEnergy EV-to-EBITDA Historical Data

The historical data trend for Solarvest BioEnergy's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solarvest BioEnergy EV-to-EBITDA Chart

Solarvest BioEnergy Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.95 -5.13 -5.30 -6.67 -2.06

Solarvest BioEnergy Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.17 -2.53 -2.06 -2.13 -2.82

Competitive Comparison of Solarvest BioEnergy's EV-to-EBITDA

For the Biotechnology subindustry, Solarvest BioEnergy's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solarvest BioEnergy's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Solarvest BioEnergy's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Solarvest BioEnergy's EV-to-EBITDA falls into.



Solarvest BioEnergy EV-to-EBITDA Calculation

Solarvest BioEnergy's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4.277/-1.524
=-2.81

Solarvest BioEnergy's current Enterprise Value is C$4.28 Mil.
Solarvest BioEnergy's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solarvest BioEnergy  (TSXV:SVS.H) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Solarvest BioEnergy's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.025/-0.025
=At Loss

Solarvest BioEnergy's share price for today is C$0.025.
Solarvest BioEnergy's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.025.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Solarvest BioEnergy EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Solarvest BioEnergy's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Solarvest BioEnergy (TSXV:SVS.H) Business Description

Traded in Other Exchanges
N/A
Address
301 - 1228 Hamilton Street, Vancouver, BC, CAN, V6B 6L2
Solarvest BioEnergy Inc is a Canada based algae biologics company whose production platform provides flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. The company has also initiated a program for the expression of CBD and THC to be produced.

Solarvest BioEnergy (TSXV:SVS.H) Headlines

No Headlines